Trial intelligence / Profile preview

Impact of H. pylori Eradication on Salivary Microbiome

NCT03730766Phase 4Unknown

Sponsor
Shanghai Jiao Tong University School of Medicine
Start
Aug 2018
Primary completion
Nov 2018
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 4 trial of esomeprazole, bismuth subcitrate, amoxicillin, metronidazole in Helicobacter pylori infection, sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.

02

Drugs

esomeprazolebismuth subcitrateamoxicillinmetronidazole
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT03730766.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03730766.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call